REAL Space Navigator offers access to over 640 million pharma-oriented compounds Kiev, Ukraine, and Sankt Augustin, Germany. Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks (150,000) and screening compound libraries (2,400,000), and BioSolveIT GmbH, premium provider of medicinal chemistry software, today announced the launch of the […]
Schrödinger Cryo-EM Initiative (SCI) brings together a broad network of renowned Cryo-EM centers to develop novel therapeutics using Schrödinger’s drug discovery platform New York, NY － Schrödinger, a world-leading provider of molecular simulations and drug discovery software solutions dedicated to revolutionizing drug discovery through advanced computational methods, today announced the launch of Schrödinger Cryo-EM Initiative […]
Appoints Dr. Scott Lyon as Director of Business Development located on West Coast, USA Moves to larger Headquarters in Cambridge, UK CAMBRIDGE, UK – Optibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge […]
CDD Expansion News CDD’s primary mission has always included the promotion and empowerment of collaborations for our customers. Sometimes, these customer collaborations are isolated within groups located across the hall from one another, and other times they involve truly global partnerships. What you may not realize is that CDD also encourages and adopts this collaborative […]
Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]
Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]
New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has received a payment from Sanofi for reaching a major milestone in its multi-year, multi-target drug discovery collaboration. The project in which the milestone was achieved is one of several programs that Schrödinger is […]
BUDAPEST, Hungary and TOULOUSE, France and BOSTON — ChemAxon, a leading provider of cheminformatics software for life sciences announces a strategic partnership with DEXSTR, an innovative provider of Scientific Knowledge Management solutions. Organizations have an unprecedented quantity of continuously generated unstructured data. Inquiro, DEXSTR’s Scientific Knowledge Management System significantly enhances the R&D digitalization process, turning unstructured data into actionable insight. […]
We are pleased to announce Schrödinger software release 2017-4, which is available for download now. This quarterly release includes usability improvements and performance enhancements across all of our software. Click here to learn more about new features in 2017-4.
Collaboration to Focus on Computational Chemistry and Molecular Recognition in the Human Body NEW YORK, NY and SHANGHAI, CHINA (November 7, 2017) – Schrödinger, Inc., a world-leading provider of advanced molecular simulations and drug discovery software solutions, and ShanghaiTech University in China have reached an agreement to develop a strategic partnership and establish the Shanghai […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
